Filing Details
- Accession Number:
- 0001883850-23-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-27 16:37:48
- Reporting Period:
- 2023-03-23
- Accepted Time:
- 2023-03-27 16:37:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-23 | 2,192 | $806.47 | 18,409 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,473 | Indirect | 2021 GRAT |
| Common Stock | 5,000 | Indirect | 2022 GRAT |
| Common Stock | 1,480 | Indirect | By 401(k) Plan |
| Common Stock | 1,897 | Indirect | By Trust |
| Common Stock | 461 | Indirect | by Trust for Daugh |
| Common Stock | 460 | Indirect | by Trust for Son |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 9, 2023.
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
Billionaire Hedge Funds
